news

Y chromosome discovery could advance personalised medicine

Posted: 27 November 2023 | | No comments yet

Researchers have completely decoded the human Y chromosome, which may result in more effective treatment for digestive disorders.

Leukaemia

Researchers Lanlan Chen and Dr Guoyue Lv from the First Hospital of Jilin University have achieved a breakthrough in human genetics, by the complete decoding of the human Y chromosome. This, alongside advancement in third-generation sequencing technologies, will revolutionise scientists’ knowledge of the genetic underpinnings of digestive disorders and lead to more personalised and effective treatment methods.

The Y chromosome is the smallest of the human chromosomes and has long been difficult to study because of its complex repetitive structure. However, recent advancements in sequencing technologies have allowed researchers to discover the intricate details of this genetic region, which has led to greater understanding of its role in sex determination and its potential impact on various diseases, including those affecting the digestive system.

Y chromosome sequence

By completing the Y chromosome sequence, a comprehensive reference is given for identifying genetic variations that may contribute to digestive diseases. This information is essential for understanding the ‘missing heritability’ problem, where the proportion of disease risk attributable to known genetic factors is not what is expected based on heritability estimates.

 

Reserve your FREE place

 


Reduce preclinical failures with smarter off-target profiling

24 September 2025 | 15:00PM BST | FREE Webinar

Join this webinar to hear from Dr Emilie Desfosses as she shares insights into how in vitro and in silico methods can support more informed, human-relevant safety decisions -especially as ethical and regulatory changes continue to reshape preclinical research.

What you’ll learn:

  • Approaches for prioritizing follow-up studies and refining risk mitigation strategies
  • How to interpret hit profiles from binding and functional assays
  • Strategies for identifying organ systems at risk based on target activity modulation
  • How to use visualization tools to assess safety margins and compare compound profiles

Register Now – It’s Free!

 

Third-generation sequencing technologies are pivotal for deciphering the complicated genomics of digestive diseases, as they can generate long, continuous DNA reads. They enable the detection of structural variations, like copy number variations and inversions, which could have an important part in disease susceptibility and progression. Detecting structural variations was previously inaccessible with older sequencing methods.

Targeted therapies

Combining complete Y chromosome sequencing and third-generation sequencing technologies has great promise for advancing digestive disease research. Finding novel genetic variants and explaining their functional roles means that researchers can better understand the mechanisms underlying digestive disorders.

Also, completing the Y chromosome sequence provides new opportunities for exploring sex-specific genetic effects. In many digestive disorders, sex differences in disease susceptibility and progression are well-documented. However, the underlying genetic mechanisms remain largely unknown. The Y chromosomes has unique genetic content and expression patterns, so could possess a vital role in these sex disparities.

These advancements could transform researchers’ understanding of digestive disorders, resulting in more personalised and effective treatment strategies to improve patient outcomes.

This study was published in eGastroenterology.

Leave a Reply

Your email address will not be published. Required fields are marked *